Kailera Therapeutics IPO Indicating $24/Share On 559K Shares; IPO Priced At $16/Share On 39.06M Shares

Benzinga Newsdesk www.benzinga.com Neutral 91.4%

Neg 0% Neu 91.4% Pos 0%

Comments

No comments yet. Be the first!